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Abstract
Stimulation of either GABAA or GABAB receptors within the nucleus accumbens shell strongly enhances food intake in rats.
However the effects of subtype-selective stimulation of GABA receptors on instrumental responses for food reward are less
well characterized. Here we contrast the effects of the GABAA receptor agonist muscimol and GABAB receptor agonist
baclofen on instrumental responding for food using a second order reinforcement schedule. Bilateral intra-accumbens
administration of baclofen (220–440 pmol) stimulated responding but a higher dose (660 pmol) induced stereotyped oral
behaviour that interfered with responding. Baclofen (220–660 pmol) also stimulated intake of freely available chow.
Muscimol (220–660 pmol) was without effect on responding for food on this schedule but did stimulate intake of freely
available chow. Unilateral administration of either baclofen or muscimol (220 pmol) induced similar patterns of c-fos
immunoreactivity in several hypothalamic sites but differed in its induction in the central nucleus of the amygdala. We
conclude that stimulation of GABAA or GABAB receptors in the nucleus accumbens shell of rats produces clearly
distinguishable effects on operant responding for food.
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Introduction
The nucleus accumbens is a key structure within neural systems
that have an established role in feeding. Pharmacological evidence
suggests specific and dissociable roles for dopamine, opioid
peptides, acetylcholine and amino acids in controlling sub-
components of food motivated behaviours [1]. GABA in the
accumbens shell plays a fundamental role in the modulation of
food intake; inhibition of GABA metabolism, leading to increased
local concentrations of GABA, stimulates feeding behaviour [2].
Intra-accumbens administration of GABA agonists also leads to
a significant selective increase in short-term intake [2–5].
The accumbens receives numerous inputs signalling the
presence and location of reward-related stimuli and is thought to
mediate response selection and/or adaptive switching [6–8].
Electrophysiological studies demonstrate that response to re-
ward-related stimuli is associated with inhibition of a subset of
accumbens neurons during appetitive and consummatory beha-
viors [9,10]. These authors suggest that the sustained inhibition of
GABA-ergic projection neurons, perhaps through activation of
fast-spiking GABA-ergic interneurons [11], disinhibits target
regions, permissively gating and maintaining feeding behaviors.
Disinhibition of a lateral hypothalamic target is believed to be
crucial to GABA stimulation of feeding through a direct or indirect
pathway [4].
Evidence for increased feeding following pharmacological
activation of accumbens GABAA receptors is almost entirely
restricted to consummatory motor actions [12,13]. Kelley and
colleagues [1] hypothesise that this arises through activation of
a subset of hypothalamic behavioral control columns [14] directly
exciting relevant hindbrain motor pattern generators. Wirtshafter
and Stratford [15,16] have recently demonstrated that intra-
accumbens administration of the GABAA agonist muscimol can
also enhance responding for food on both a progressive ratio
schedule and on a fixed ratio schedule.
There is little evidence to suggest that GABAA and GABAB
agonists infused into the accumbens shell exert differential effects
on either the appetitive or consummatory components of feeding
behavior [2,5] or that they have other differential behavioural
effects. However we have shown that the effects of intra-
accumbens infusions of either the GABAA receptor agonist
muscimol or the GABAB receptor agonist baclofen on feeding-
related behaviours can be distinguished [17]. The data suggested
that the action of baclofen mimics more ‘natural’ motivational
manipulations such as a short period of food withdrawal.
The studies reported here investigated the effects of bilateral
intra-accumbens administration of muscimol or baclofen on
instrumental responding for food using a second order schedule
which includes an initial period of responding without reward
followed by a longer phase in which food is available [18]. Subjects
in the second and third experiments received a final unilateral
administration of either baclofen or muscimol. Selected brains
were subsequently processed to visualise c-fos immunoreactivity as
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a measure of neuronal activity in different brain areas relevant to
the induction of feeding behaviour [4,19].
Results
Experiment 1
Seven animals had bilateral placements within the shell of the
nucleus accumbens (Figure 1A) and the remaining five did not
meet the criteria for bilateral placements and were excluded from
further analysis. The free intake test (440 pmol baclofen) revealed
a significant stimulation of chow consumption by GABAB receptor
stimulation (saline: 2.1 g60.27; baclofen: 4.6 g60.38, P,0.001).
Baclofen increased reinforced responses on the second order
schedule (Fig. 2: F3,18 = 10.95, P,0.001). The effect was maximal
at 220 pmol and significantly greater at this dose than at either
110 or 440 pmol (p,0.05). Non-reinforced responses were also
increased at 220 pmol baclofen (Fig. 2: F3,18 = 4.03, P,0.05)
There was no effect on responding on the inactive lever (Fig. 2:
F3,18 = 1.62, NS).
Experiment 2
Eight animals had bilateral placements within the shell of the
nucleus accumbens (Figure 1B) and the remaining four did not
meet the criteria for bilateral placements and were excluded from
further analysis. 660 pmol baclofen resulted in a significant
stimulation of free chow intake (saline: 1.9 g60.17; baclofen:
4.860.54, P,0.001).
Baclofen increased reinforced responses on the second order
schedule (Fig. 3B: F2,16 = 14.44, P,0.001), but only at the
220 pmol dose. There was no effect of baclofen on either non-
reinforced responses or responses on the inactive lever in this
experiment. A plot of cumulative responses (Fig. 4A) demonstrated
a uniform enhancement of responding throughout the test session
and did not suggest a differential enhancement of responding in
Figure 1. Infusion sites for baclofen. Infusion sites for animals used in Experiment 1 (A) and Experiment 2 (B), plotted on drawings taken from
Paxinos and Watson [58].
doi:10.1371/journal.pone.0040057.g001
Figure 2. Operant responding following baclofen infustion.
Reinforced and non-reinforced active lever, and inactive lever respond-
ing in a 30 minute test session following bilateral intra-accumbens
infusion of baclofen in Experiment 1.
doi:10.1371/journal.pone.0040057.g002
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either the initial appetitive or the later consummatory component
of the schedule. This was confirmed by an analysis of response
rates in the appetitive (first 5 minutes) and consummatory
(remaining 25 minutes) phases of the test session (Table 1). The
response rate following infusion of 220 pmol baclofen was higher
in both the appetitive (P,0.05) and consummatory (P,0.01)
phase than in animals infused with vehicle. Figure 4B plots the
distribution of intervals between the 5th and 1st lever presses of the
schedule. It demonstrates that the animals normally paused in
their responding as the light illuminated after the fifth lever press.
The next response was typically delayed until after the light was
extinguished. Intra-accumbens infusion of 220 pmol baclofen was
associated with a small leftward shift of the distribution, indicating
a more rapid return to lever pressing but only after the light was
extinguished. Infusion of 660 pmol baclofen, by contrast, resulted
in 3/8 animals emitting 10 or fewer lever presses in the entire
session. Responding by the remainder was also at a low level
(Figure 3B) and such responses frequently occurred while the light
was still illuminated (Figure 4B).
The detailed video analysis of the instrumental test sessions
revealed that infusion of 660 pmol baclofen, in addition to
reducing instrumental responses, also led to a marked increase in
oral stereotypy and a substantial decrease in both active behaviour
(typically locomotor responses) and rearing (Table 2: dose x
behaviour interaction F8,56 = 6.27, P,0.001). The oral stereotypy
was primarily manifested as licking and chewing of the mesh
flooring of the cage, but was also sometimes directed towards the
response levers or food magazine. The stereotypy also altered the
form of grooming responses, with a breakdown of the usual
syntactic chain [20]. Instead 6/8 animals predominantly groomed
either the tail or genitals. None of these patterns of changed
response were apparent at a dose of 220 pmol baclofen; the only
change at this dose was an increase in time spent at the magazine
as a consequence of increased feeding (data not shown), which is
consistent with the data for instrumental responses. There were no
obvious rostrocaudal differences in evoked behaviour, and aversive
responses (e.g. defensive treading) were not apparent in this test
situation.
In the subsequent free intake tests, baclofen stimulated chow
consumption at both 220 and 660 pmol (Figure 3A: F2,16 = 14.53,
P,0.001). The stimulation of intake at 660 pmol was similar
(4.1 g60.69) to that observed in the probe test that preceded the
tests of instrumental responding.
Unilateral infusion of 0.5 ml of 220 pmol/ml baclofen was
associated with a marked increase in c-fos immunoreactivity in
most, though not all, of the brain areas that were sampled (Table 3:
side x area interaction F9,36 = 27.9, P,0.001). The cell count was
elevated ipsilaterally in all sampled areas with the exception of the
basolateral nucleus of the amygdala (Table 3).
Experiment 3
Eight animals had bilateral placements within the shell of the
nucleus accumbens (Figure 5) and the remaining four did not meet
the criteria for bilateral placements and were excluded from
further analysis. The initial infusion of 660 pmol muscimol
stimulated chow intake (saline: 1.98 g60.27; muscimol:
5.61 g60.58; P,0.001).
Intra-accumbens infusion of muscimol had no effect on
responding on the second order schedule (Figure 6B; F3,21,1)
for reinforced, non reinforced responses or responses to the
inactive lever. There was no evidence of responding being
suppressed below baseline at higher doses of muscimol and the
specificity of responding to the active lever was also maintained.
There was also no evidence for any differential effect of muscimol
Figure 3. Food intake and operant responding following baclofen infusion. A: Intake of freely available chow in a 30 minute test session
following bilateral intra-accumbens infusion of baclofen in Experiment 2. B: Reinforced and non-reinforced active lever, and inactive lever responding
in a 30 minute test session following bilateral intra-accumbens infusion of baclofen in Experiment 2.
doi:10.1371/journal.pone.0040057.g003
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on responding during the appetitive and consummatory phases of
the test sessions (Table 1).
Statistical analysis of the detailed video data from the
instrumental test sessions using vehicle and 660 pmol muscimol
revealed no significant interaction between dose and class of
behaviour (Table 2: F8,56 = 0.33, NS), although there was
a marginally significant increase in oral sterotypy at a dose of
660 pmol muscimol (Table 2). As in Experiment 2, there were no
Figure 4. Temporal structure of operant responding following baclofen infusion. Effects of bilateral intra-accumbens infusion of baclofen
(Experiment 2) on A. Cumulative lever presses, B. inter – lever press intervals (5th to 1st press on FR5 requirement).
doi:10.1371/journal.pone.0040057.g004
Table 1. Rates of responding in the appetitive and
consummatory phases of Experiments 2 and 3.
Treatment Phase Rate (responses/minute)
Vehicle Appetitive 2.7360.49
Consummatory 1.3560.25
220 pmol baclofen Appetitive 4.6060.35*
Consummatory 3.7460.51**
660 pmol baclofen Appetitive 2.6860.68
Consummatory 1.0260.54
Vehicle Appetitive 1.5560.41
Consummatory 1.2160.41
220 pmol muscimol Appetitive 2.2860.33
Consummatory 1.0360.29
440 pmol muscimol Appetitive 1.4860.40
Consummatory 1.4160.49
660 pmol muscimol Appetitive 1.2860.22
Consummatory 1.0860.32
Significant differences:
*p,0.05 compared with vehicle.
**p,0.01 compared with vehicle.
doi:10.1371/journal.pone.0040057.t001
Table 2. Effects of bilateral intra-accumbens infusion of
saline, baclofen (660 pmol) or muscimol (660 pmol) on the
duration (s) of different behaviour patterns observed during
operant test sessions.
vehicle baclofen BEHAVIOUR vehicle muscimol
16.663.9 3006103** Oral 4.762.6 20.865.1*
1142646.1 5656106** Active 1126675.4 1059685.6
182632.3 107645.1 Rear 156633.8 208637.2
83.6613.3 73.7631.5 Lever 91.3616.9 68.8615.2
89.9620.5 74.3627.7 Magazine 68.2627.9 56.8611.8
40.9612.2 27.4622.3 Ingest 29.2619.6 31.5616.3
155633.2 2996128 Groom 182624.1 154620.9
83.3639.9 3306147 Inactive 148664.7 213.569.7
24.6616.1 79.4638.3 Off 4.864.8 2.661.3
Behavior categories. Oral: oral stereotypies, including repeated licking and
mouthing, but not of the body; Active: rapid moving around the test chamber;
Rear: body supported on rear limbs only, but forelimbs may be against the sides
of the test chamber; Lever: pressing either operant lever; Magazine: head
inserted into the food magazine; Ingest: holding and eating a food pellet;
Groom: body care movements using the mouth or forelimbs; Inactive: body
supported on all four limbs with no locomotor movement; Off: not visible on
screen.
*p,0.05 compared with vehicle.
**p,0.01 compared with vehicle.
doi:10.1371/journal.pone.0040057.t002
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obvious rostrocaudal differences in evoked behaviour, and aversive
responses (e.g. defensive treading) were absent.
Intra-accumbens infusion of muscimol resulted in a dose related
increase in food intake over 30 minutes (Figure 6A: F3,21 = 13.76,
P,0.001). The stimulation of chow intake at 660 pmol muscimol
was 5.6 g60.47, similar to that recorded in the probe test
preceding the tests on the instrumental schedule.
Unilateral infusion of 0.5 ml of 220 pmol/ml muscimol was
associated with a marked increase in c-fos immunoreactivity in
most brain areas (Table 3: side x area interaction F9,36 = 24.4,
P,0.001). The cell count was elevated ipsilaterally in all brain
areas sampled with the exception of the the arcuate nucleus of the
hypothalamus (Table 3, Figure 7) and the basolateral and central
nuclei of the amygdala (Table 3, Figure 8).
Although Experiments 2 and 3 were not designed to allow
explicit contrast of c-fos immunoreactivity as a consequence of
intra-accumbens infusion of either baclofen or muscimol, a pre-
liminary analysis was conducted. The counts on the vehicle-
infused sides were very similar for the two drugs, with no main
effect or interaction in an ANOVA restricted to these data
(Table 3: F’s,1). There was a significant experiment x drug x side
interaction for the full data set (F9,72 = 2.58, P= 0.012). When
restricted by brain area there was a single significant interaction
for the central nucleus of the amygdala (F1,8 = 8.13, P= 0.021) that
resulted from increased ipsilateral activation by baclofen, but not
by muscimol (Table 3).
Discussion
Experiments 1 and 2 demonstrated that intra-accumbens
administration of the GABAB receptor agonist baclofen (220–
440 pmol) enhances instrumental responding for food on a second
order reinforcement schedule and that a higher dose of baclofen
(660 pmol) induced premature non-reinforced responding and
also led to high levels of oral stereotypy. Baclofen stimulated the
intake of freely available chow in both experiments. Experiment 3
demonstrated that equivalent doses of the GABAA receptor
agonist muscimol did not facilitate responding on the second
order schedule although chow intake was increased.
Our results raise several methodological questions. First, the
absence of any obvious rostrocaudal pattern of responding and of
aversive responses may seem unexpected [21]. However the
majority of the placements for infusions were in the rostral part of
the accumbens, anterior to the location where aversive reactions to
muscimol infusion have been observed [21–23]. In addition our
animals had very extensive habituation to the test environments,
both prior to and following surgery, and we were also using
a different strain of rat than these earlier studies. Second, we used
a relatively large number of infusions (typically 8–10) in each
animal. However our experimental design for experiments 2 and 3
incorporated an intake test with the same drug dose at the very
beginning and end of testing for each animal. The data
demonstrated that there was no change in responsiveness over
this period.
Several possible explanations for the enhancement of in-
strumental responding by baclofen can be discounted. Psychomo-
tor activation is unlikely since we observed no change in active
behaviour at 220 pmol baclofen and suppression at the higher
dose of 660 pmol. Failure of inhibitory control is also unlikely
since 220 pmol baclofen was not associated with any loss of
selectivity between responding to the active and inactive levers and
did not lead to premature responding on the active lever while the
CS was still illuminated (Figure 4B). Earlier studies have
implicated the accumbens core, rather than the shell, in the
Table 3. Effects of unilateral intra-accumbens infusion of
baclofen (220 pmol) or of muscimol (220 pmol) on c-fos
activity in selected brain regions.
vehicle baclofen BRAIN AREA vehicle muscimol
34.263.4 51.864.6* VP 31.666.8 49.268.2**
170.0633.0 449.8646.6** LH1 135.2620.6 521.4666.5**
122.8610.5 299.8621.8** LH2 122.0610.5 269.4613.4**
97.6610.2 227.0615.3** LH3 101.0610.4 227.0629.8**
114.067.6 229.0615.0** LH4 118.4611.3 183.6617.4*
109.065.9 157.669.1** Arc 157.2611.5 204.2616.1
211.8625.5 310.0649.0* PVN 222.2614.7 347.4635.4**
99624.8 137.0623.1* CeA 82.267.2 81.864.4
71.465.9 106.6612.6 BLA 71.8611.5 74.669.5
77.0610.3 123.2619.4* VTA 43.8612.0 84.6611.7*
Counts of labelled neurons in each of the brain regions, given for (left columns)
the vehicle infused side and the baclofen infused side and (right columns) the
vehicle infused side and the muscimol infused side. Significant differences from
vehicle are shown:
*p,0.05;
**p,.01.
The areas investigated were VP (ventral pallidum at b–0.26 mm); LH1 (lateral
hypothalamus at b–1.6 mm); LH2 (lateral hypothalamus at b–2.6 mm); LH3
(lateral hypothalamus at b–3.6 mm); LH4 (lateral hypothalamus at b–4.3 mm);
Arc (arcuate nucleus at b–2.8 mm); PVN (paraventricular nucleus of the
hypothalamus at b–1.88 mm); CeA (central nucleus of the amygdala at b–
3.14 mm); BLA (basolateral nucleus of the amygdala at b–3.3 mm); VTA (ventral
tegmental area at b–5.3 mm). All coordinates from Paxinos and Watson [58].
doi:10.1371/journal.pone.0040057.t003
Figure 5. Infusion sites for muscimol. Infusion sites for animals
used in Experiment 3, plotted on drawings taken from Paxinos and
Watson [58].
doi:10.1371/journal.pone.0040057.g005
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modulation of impulsive control and response to delayed re-
inforcement [24]. Although a simple motivational enhancement
would be consistent with the data for baclofen, taken in isolation, it
would not explain why there is a dissociation between the effects of
baclofen and muscimol on instrumental responding despite similar
increases in consumption during the free intake tests.
The stimulatory effect of 220 pmol baclofen on instrumental
responding might arise from an enhancement of the hedonic
properties of either the primary reinforcer (food) or of the visual
CS. The former seems unlikely since instrumental responding
increased even during the appetitive phase of the schedule
(Figure 4A, Table 1). There is evidence that a CS associated with
a palatable reinforcer can evoke positive hedonic responses [25],
but such effects are only evident after a small number of pairings of
CS and reinforcer and are greatly diminished or absent following
more extended training [26].
Finally, the stimulatory effect of 220 pmol baclofen on
instrumental responding might result from an increase in the
salience, or incentive value, of the cues provided by the schedule,
accounting for the more rapid return to lever pressing at the offset
of the light CS (Figure 4B) and a uniform increase in lever pressing
during both phases of the schedule (Figure 4A). It is also consistent
with unchanged responding on the inactive lever or in non-
reinforced lever presses while the visual CS is illuminated (Figure 2,
3B). This explanation is attractive because of the similarities
between the behavioural effects of electrical stimulation of lateral
hypothalamus and GABA-ergic stimulation of the accumbens [2]
and the arguments in favour of an incentive-based explanation in
the former case [27]. It is possible that this effect might also oppose
any development of satiety later in the test session. The response
rate of animals infused with vehicle decreases after 15 minutes
which might indicate the development of satiety. However the
actual amount of of food ingested by this point is relatively small,
and is unlikely to exceed 0.7 g, which is less than half the amount
of increase in free intake at this dose in an earlier study [17].
In Experiment 3 muscimol was without effect on instrumental
responding in the second order schedule. Zhang et al [12] reported
that muscimol (350–1750 pmol) did not enhance responding on an
arithmetic progressive ratio (PR2) schedule although there was
some evidence of increased responding at 876 pmol. Wirtshafter
and Stratford [15,16] have recently shown that this dose
significantly enhances responding on both an arithmetic PR6
and a FR5 schedule. Our pilot observations indicated that doses at
these higher levels induced significant motor side effects that
interfered with responding, probably because the Lister hooded
strain of rat used here is more sensitive to such effects than the
Sprague Dawley strain used in earlier studies. One critical
difference between progressive ratio and second order schedules,
especially the one used in the present study, is that reinforcement
density is high at the beginning of the progressive ratio test session
and then declines, whereas the opposite is the case with the
schedule used here. Reinforcement density is consistently high in
a fixed ratio schedules. These differences suggest that baclofen
enhances responding, at least in part, through increasing the
incentive value of the CS associated with lever pressing whereas
muscimol has a broader motivational effect that is more dependent
on immediate reinforcement from the food reward.
The detailed behavioural observations made in Experiments 2
and 3 revealed evidence of oral stereotypy and abnormal
grooming patterns following 660 pmol baclofen (Table 2) sufficient
to interfere with instrumental responding, thus leading to an
inverted ‘U’ dose response function (Figures 2 and 3B). Aspects of
this behaviour, especially the repetitive grooming of the tail and
also of the genital area, resemble that described following electrical
Figure 6. Food intake and operant responding following baclofen infusion. A. Intake of freely available chow in a 30 minute test session
following bilateral intra-accumbens infusion of muscimol. B. Reinforced and non-reinforced active lever, and inactive lever responding in a 30 minute
test session following bilateral intra-accumbens infusion of muscimol.
doi:10.1371/journal.pone.0040057.g006
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stimulation of the lateral hypothalamus [28] and was absent
following infusion of muscimol (Table 2).
Baclofen and muscimol produced similar c-fos activation
patterns (Table 3), with the exception of the arcuate nucleus of
the hypothalamus and the central nucleus of the amygdala
(Figures 7 and 8), broadly comparable to those reported for
muscimol infused unilaterally [19] and bilaterally [4]. The output
of the accumbens shell is from the GABAergic medium spiny
neurons [29] which project ipsilaterally [30,31]. Infusion of GABA
agonists will release target areas from inhibition, thus giving rise to
elevated levels of c-fos immunoreactivity. Unilateral infusions also
distinguish between neuronal activation resulting from the drug
infusion from any non-specific activation due to the infusion
procedure and associated handling [19].
The increase in LH c-fos supports the model advanced by Kelley
et al [1], whereby inactivation of the accumbens shell leads to
activation of the LH which, when transmitted to the relevant
behavioural control column activates approach to food and
feeding [14]. We observed this pattern of c-fos activation after
infusion by either drug, at a dose which produced the feeding
response without any gross alterations in motor behavior.
The rostrocaudal pattern of activation reported here within LH
is very similar to that reported by Stratford [19]. Some of the LH
activation is in sub-regions from which feeding may be elicited.
Duva et al [32] have shown in the rat that there are afferents from
the nucleus accumbens to the tuberal region of LH where NMDA
elicits eating. Baldo et al [33] have shown that muscimol infused
into the nucleus accumbens shell results in the activation of c-fos
within orexin/hypocretin cells in the perifornical area of the LH.
Within the LH, it seems quite probable that much of the c-fos
activation is trans-synaptic. Glutamate is most probably the
transmitter which gives rise to the excitation of the LH neurons,
and hence c-fos activation, as it has been shown by Stanley et al
[34,35] to be the key neurotransmitter within the hypothalamus in
terms of the activation of feeding behavior.
Both the PVN and the arcuate are considered to be involved in
the regulation of feeding [36]. Both these nuclei receive inputs
from the LH [37]. We found ipsilateral activation of the PVN by
both drugs. However in the arcuate nucleus, ipsilateral activation
of c-fos was only seen after baclofen infusion (Figure 7, Table 3).
Baldo et al. [33] reported elevated c-fos expression in the arcuate
after bilateral infusion of a substantially higher dose of muscimol
than was used here. The ipsilateral activation of LH, PVN and
arcuate by baclofen is consistent with an interpretation of the
induced feeding behavior being similar to normal, homeostatic,
feeding [17].There was an increase in c-fos activation ipsilaterally
in CeA after baclofen infusion (Figure 8, Table 3). There is
a projection of LH to CeA [38–40] and there is also evidence for
a direct projection from the accumbens shell to CeA [30]. The
possibility of greater activation of the CeA by baclofen is of interest
Figure 7. C-fos response in arcuate nucleus. Representative sections illustrating c-fos immunoreactivity in the arcuate nucleus of the
hypothalamus following intra-accumbens infusion with A: saline (baclofen control); B: 220 pmol baclofen; C: saline (muscimol control); D: 220 pmol
muscimol. All sections are x100 magnification and b–2.8.
doi:10.1371/journal.pone.0040057.g007
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because of the suggestion by Balleine and Killross [41] that the
CeA encodes incentive salience. This proposal is supported by
a recent study by Mahler and Berridge [42] which demonstrated
that manipulation of CeA opioid transmission selectively enhanced
the attractiveness of a prepotent stimulus in an autoshaping
paradigm. Thus the interpretation offered here for the role of
incentive salience in the behavior of baclofen treated animals may
reflect the input from the CeA to the accumbens [43], which may
itself be enhanced by the infusion of baclofen into the accumbens.
An alternative locus for differences between the effects of the
two drugs is within the accumbens itself. The accumbens is
a heterogeneous structure with a complex set of both afferents and
efferents, which can be considered to form a number of different
neuronal ensembles [44]. The ability of the accumbens to produce
output signals which differentiate incentive salience and hedonic
impact has recently been demonstrated by Smith et al [45]. They
observed that the response of neurons in the ventral pallidum is
modified by the infusion of either amphetamine or opiates into the
accumbens. This finding opens up the possibility that baclofen
may also modify the output of the accumbens, perhaps to the
central nucleus of the amygdala, in such a way as to signal an
increase in incentive salience for the conditioned stimulus.
Both GABAA and GABAB receptors are widely distributed in
the striatum, and have been reported on both interneurons and
projection neurons [46–48]. As elsewhere in the CNS, it seems
probable that the metabotropic GABAB receptors will be located
both presynaptically, as autoreceptors and heteroreceptors, as well
as on the postsynaptic cell, although in this case peri- and extra-
synaptically [48]. GABAB receptors can act in a neuromodulatory
fashion by both presynaptic and postsynaptic mechanisms to
regulate glutamate transmission [49]. In contrast, the GABAA
receptors are only located on postsynaptic cells [50], although
some subtypes may be located extrasynaptically [51].
All the physiologically identifiable classes of striatal GABAergic
interneurons have been shown to produce fast, potent, mono-
synaptic inhibition of MSNs [52] which would be consistent with
action through GABAA receptors especially at synapses located on
the perikarya [53]. Infusion of muscimol could therefore
completely inhibit MSN output as a result of its high affinity to
GABAA receptors [54]. In contrast, baclofen may be acting at the
dendrites of the MSNs through both presynaptic inhibition of the
glutamatergic input there [29] and postsynaptic effects including
direct modulation of glutamatergic NMDA synapses [29,49]. At
moderate doses baclofen may decrease excitatory drive to both the
interneurons and the MSNs rather than directly inhibiting the
MSNs. Thus the two GABAergic agonists may produce different
effects as a result of the more potent and over-riding effect of
muscimol as compared to the more subtle impact of baclofen
which could permit other inputs to the accumbens to continue to
influence behavior. The interactions between glutamatergic inputs
to the accumbens is itself complex [55–57] and the effects of
baclofen may be due to neuromodulatory changes in this, possibly
changing the balance between the interplay of cortex, amygdala
and hippocampus.
In conclusion, we have shown that intra-accumbens stimulation
of GABAB receptors, but not GABAA receptors, increases
Figure 8. C-fos response in central nucleus of the amygdala. Representative sections illustrating c-fos immunoreactivity in the central nucleus
of the amygdala following intra-accumbens infusion with A: saline (baclofen control); B: 220 pmol baclofen; C: saline (muscimol control); D: 220 pmol
muscimol. All sections are x100 magnification and b –3.14.
doi:10.1371/journal.pone.0040057.g008
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instrumental responding for food on a second order schedule of
reinforcement. In addition we observed differential patterns of
stereotypy and other abnormal behaviour at higher doses of either
GABAA or GABAB agonists which, in the case of the GABAB
receptor agonist baclofen, were likely to be sufficient to limit
further increases in instrumental responding. This represents some
of the first evidence of a clear differentiation of the effects of intra-
accumbens stimulation of these two subtypes of GABA receptor. It
also provides the first evidence that stimulation of accumbens shell
GABAB receptors can enhance instrumental responding for food,
most likely by increasing the incentive salience of discrete CS’s
within the second order schedule that we used for these studies.
Materials and Methods
Ethics Statement
The experiments were carried out in full compliance with the
Animals (Scientific Procedures) Act 1986. UK Home Office
Project License 90/60755 was approved following review by the
University of Sussex Local Ethical Review Committee.
Animals
Three separate groups of naı¨ve male Lister hooded rats (Harlan,
United Kingdom, N = 12, 175–200 g initially) were used, one for
each experiment. Holding and test rooms were maintained at
controlled temperature (19–22uC) and humidity (45–55% satura-
tion) with a 12 hr light/dark cycle. Animals had ad libitum access to
water throughout the study but access to food was restricted (see
below). They were housed in groups of three or four during the
period of instrumental training and moved to individual housing at
least one week prior to surgery.
Instrumental Schedule
Food was restricted using a daily ration of 14–16 g per rat to
maintain weight at 85%–90% of free feeding animals. The animals
were then trained to respond on a second order schedule [18]
using standard two lever operant cages (Paul Fray, Cambridge).
Initial habituation to consumption of food pellets in the operant
cage was provided on a 120 s random time schedule for 30
minutes (2 days). The animals were then progressively trained on
an FR1 and then a FR5 schedule (4–8 days). Active and inactive
levers were counterbalanced across individuals and the cue light
was illuminated for 4 s both prior to and following pellet delivery.
Further training (4–8 days) introduced the animals to the second
order schedule in which the animals would press a lever 5 times
(reinforced lever presses) to receive an 8 second light CS. Further
lever presses while the light was illuminated had no programmed
consequences (non-reinforced lever presses). During the first 5
minutes of the 30 minute test session the animals only received
light CS’s (‘appetitive phase’). For the remainder of the session the
animals received 5645 mg Noyes AI grain pellets after 5
illuminations of the light CS and hence after 25 lever presses
(‘consummatory phase’). Food was delivered 4 s after illumination
of the light, which remained illuminated for a further 4 s. This
schedule maintains high levels of responding throughout the test
session, including the initial 5 minutes during which food reward is
not provided [18]. This initial period of responding provides
a measure of response rate that is not affected by either the
physiological or behavioural consequences of food consumption.
All lever presses were recorded and time-stamped.
Surgery
Anaesthesia was induced with 4% isoflurane in 0.5 L/min N2O
and 0.5 L/min O2, and then maintained by adjusting the
isoflurane concentration to 1.5–2.5%. Thin wall 26 g, 16 mm
stainless steel cannulae (Coopers Needleworks, UK) were im-
planted bilaterally aimed 2.2 mm dorsal to the target site in the
accumbens shell using the coordinates anteroposterior (AP)
+1.4 mm, mediolateral (ML) 60.9 mm relative to bregma (b)
and dorsoventral (DV) 25.8 mm relative to the flat skull surface
[58]. The cannulae were secured with three small screws,
Geristore dental resin and a cap of Simplex dental acrylic.
Cannula patency was maintained by 33 g wire obdurators. The
incision was treated with Cicatrin powder (GlaxoSmithKline, UK)
and the animals were administered an antibiotic (oxytetracycline
10 mg/kg) and a non-steroidal analgesic (meloxicam 2 mg/kg)
immediately, and then at 24 and 48 hours after surgery. These
drugs were mixed into a small pot of palatable wet mash to which
the animals had been accustomed prior to surgery.
Drugs
The GABAB agonist baclofen (Sigma, UK) and the GABAA
agonist muscimol (Sigma, UK) were dissolved in a vehicle of 0.9%
sterile saline, initially at ten times the required highest dose. The
pH of the baclofen solution was adjusted to 7.5 using sodium
hydroxide. Doses (see below) were chosen on the basis of earlier
reports [2,5] and minimally effective doses were determined by
several pilot experiments. Doses above those reported here were
excluded because pilot experiments indicated significant side
effects in this rat strain. Baclofen (880 pmol) induced a myorelax-
ant effect which had a relatively small impact on the animals
capacity to eat from a food dish but did impair their ability to press
an operant lever whereas muscimol (880 pmol) led to very
significant, and contrasting, motor impairment including catalepsy
and muscular rigidity.
Infusions
On test days bilateral infusions of drug or vehicle were made
simultaneously into the accumbens shell at a rate of 0.5 ml per side
over 30 seconds (1 ml of drug solution infused in total). Injectors
were left in for a further minute to allow diffusion of drug away
from the tip. The infusions were given using 31 g stainless steel
infusors which extended 2.2 mm beyond the tip of the guide
cannulae to reach the target structure. These injectors were
connected via number 10 PPE tubing to 10 ml Hamilton syringes.
A microinfusion syringe pump model 802 (Model 802, Univentor,
Malta) which held two syringes allowed bilateral infusions to be
made simultaneously. Behavioural testing followed immediately
after the infusions were completed.
Experimental Procedures
We separately examined the effect of baclofen (experiments 1
and 2) or muscimol (experiment 3) on intake of freely available
chow and on instrumental responding in the second order
schedule. Experiment 1 consisted of an initial test of free intake
using a single drug dose followed by tests of instrumental
responding at varied doses of drug. Experiments 2 and 3 consisted
of an initial test of free intake using a single drug dose, tests of
instrumental responding at varied doses of drug and, finally, tests
of free intake at the same set of doses. The latter procedure was
chosen to reveal any marked change in responsiveness with
repeated intra-cerebral drug infusions during the experimental
sequence. Drug doses were allocated using a randomised ascend-
ing Latin square design.
In Experiment 1 prior to instrumental testing, free food intake
was measured in two sessions using either vehicle or 440 pmol
baclofen, allowing at least two days between test sessions. For
instrumental testing the pre-satiated animals received infusions (in
GABA Receptors and Food Reward
PLoS ONE | www.plosone.org 9 July 2012 | Volume 7 | Issue 7 | e40057
pairs) of saline vehicle (0), 110, 220 or 440 pmol of baclofen in
a randomized order. Each instrumental test session was initiated
immediately after drug infusion was completed for the pair.
Between test sessions, animals were given at least one drug-free
instrumental session to maintain baseline responding.
In Experiment 2 the dose range was extended and the initial
intake tests used 660 pmol baclofen or saline. They were followed
by three instrumental test sessions using doses of 0, 220 and
660 pmol baclofen and a further three intake tests using the same
doses. The instrumental test sessions were videoed for later
analysis and, following histological verification of the infusion site,
the brains of five of these animals were processed to reveal c-fos
immunoreactivity.
Experiment 3 used a similar design to Experiment 2 in order to
explore the effects of equimolar doses of muscimol (0, 220, 440,
660 pmol) on instrumental responding and intake of freely
available food. The initial intake tests were carried out using
660 pmol muscimol or saline and were followed by the in-
strumental test sessions and finally intake tests at the same doses.
The instrumental test sessions were videoed for later analysis. For
both experiments 2 and 3, the behavioural categories were chosen
after preliminary screening of the recordings and definitions are
provided in the Legend to Table 2. Aversive responses, such as
defensive treading, were absent. As before, the brains of five of
these animals were processed to reveal c-fos immunoreactivity.
Perfusion and Dissection
At the end of each experiment subjects were deeply anaes-
thetised and transcardially perfused with phosphate buffered saline
followed by 10% formol saline (experiment 1) or 4% para-
formaldehyde (experiments 2 & 3). Two hours prior to perfusion,
animals were unilaterally infused with 0.5 ml of either 220 pmol/
ml baclofen (Experiment 2) or 220 pmol/ml muscimol (Experiment
3) and 0.5 ml vehicle on the contralateral side. After perfusion, the
heads were left in fixative for at least 24 hours before dissection
was completed and the brains returned to fixative for a further 24
hours. The brains were then cryoprotected in phosphate buffered
30% sucrose solution by immersing them for a minimum of 48
hours prior to freezing and storage at 280uC.
Histology and Placement Verification
Brains were sectioned coronally at 60 mm on a freezing
microtome. Every 5th section from the nucleus accumbens was
mounted on gelatinized slides stained with thionin. By comparing
key landmarks with the appropriate figures in Paxinos and Watson
[58], the location of infusion sites was determined. Gliosis could be
seen around both the cannula and around the infusion site itself.
By using the length of protusion of the infusor (2.2 mm) the
infusion site could be placed within the lower area of gliosis. A
correct placement was defined as being within the shell region
mediolaterally and between anterior-posterior co-ordinates of
1.4 mm 60.5 mm. Animals with gliosis that appeared to have
spread too extensively dorsoventrally (into other brain structures)
were also excluded from the final group for analysis.
Tissue Preparation for cFos Immunocytochemistry
After evaluation of cannula placements, additional sections from
5 selected animals were processed to reveal c-fos immunoreactivity.
Five brains were selected for each drug treatment and were chosen
on the basis of how close the infusion sites were to the target co-
ordinates and also on the basis that a minimal amount of visible
gliosis was present.
These 10 brains were sectioned coronally at 40microns on
a freezing microtome and the tissue floated in 0.9% physiological
saline. Every 6th section from relevant areas of the brain (see
Table 3) were mounted and stained with thionin. These were later
used to identify landmarks for structural identification of areas of
Fos positive nuclei present on the remaining sections. In total
sections were cut from the point at which the anterior commissure
crosses the midline of the brains at approximately bregma
+0.25 mm to approximately bregma 25.8 mm.
Method for Immunohistochemical Staining
The procedures used here are based on a protocol described by
Elmquist et al. [59] and adapted for use with free floating rat brain
sections on the basis of a protocol described by Kalinichev et al.
[60]. Staining always included one brain from each of experiments
2 and 3. Three sections from each brain were used as negative
controls for non-specific binding (omission of primary antibody.
Unless otherwise stated all washing and incubation stages de-
scribed below took place at room temperature on an orbital
shaker. The immuno-buffer was Tris buffered PBS/0.3% Triton
X-100 solution, pH 7.4.
The staining protocol was as follows:
1. Wash in immuno-buffer for 15 minutes.
2. Incubate for 30 minutes in 1% hydrogen peroxide.
3. Two 10 minute washes in immuno-buffer.
4. Block non-specific antibody binding by incubating the sections
for 1 hour in 2% goat serum (Sigma, UK) diluted in immuno-
buffer.
5. Incubate for approximately 48 hours at 4uC to 2 mls per well
of the primary (1u) antibody (a 1:20,000 dilution of Anti-c-Fos
(Ab-5) Rabbit pAb in immuno-buffer, Calbiochem supplied by
Merck Chemicals Ltd., UK).
6. Bring sections up to room temperature.
7. Three 10 minute washes in immuno-buffer.
8. Incubate for 2 hours in 0.8 ml per well of the secondary (2u)
antibody (a 1:20,000 dilution of biotinylated goat anti-rabbit
IgG (H+L) in immuno buffer, Vector Laboratories, USA).
9. Three 10 minute washes in immuno-buffer.
10. Incubate with 0.6 mls of ABC reagent for 2 hours.
11. Three 10 minute washes in a Tris-0.84 M HCl buffer (Tris-
HCl), pH 7.4.
12. Incubate with 0.6 ml of the DAB solution for 10 minutes.
13. Wash for 10 minutes with Tris-HCl buffer.
14. Wash in 0.9% physiological saline.
After this, sections were mounted from physiological saline onto
gelatinised slides. Slides were air dried and the sections fixed in
formaldehyde vapour for 1 hour. Sections were cleared in
Histoclear (R.A. Lamb, UK) then cover slipped with Histomount
(R.A. Lamb, UK). Once the mounting agent had fully set, slides
were cleaned and polished with IMS.
ABC and DAB Solutions
Horseradish peroxidase avidin-biotin complex (ABC) reagent
from an Elite standard peroxidase ABC kit (Vector Laboratories,
USA) was prepared according to manufacturer’s instructions.
Diaminobenzidine (DAB; 0.035%) was made up using a DAB Kit
for peroxidase (Vector Laboratories, USA) following the manu-
facturer’s instructions. The nickelammonium sulphate solution
was excluded thus giving a brown coloured product which gave
a good contrast for subsequent image analysis.
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Image Analysis and Quantification
Tissue sections were viewed with a Zeiss Akioskop 2 plus
microscope and images of sections were captured using an
AxioCam HRc digital camera (Carl Zeiss, UK) using AxioVision
3.1 software (Imaging Associates, Bicester, UK). Coordinates for
areas of interest were taken from the Paxinos and Watson [58] as
shown in Table 3, following those given by Stratford [18] where
specified. For the ventral pallidum, basolateral nucleus of the
amygdala and ventral tegmental area, the precise co-ordinates
were chosen on the basis of the highest level of staining within the
sections through the relevant structure for each animal. Sections
for each brain area were matched across the animals and a thionin
stained section selected as the basis for a template which could be
superimposed onto the Fos stained sections.
Counting was automated using ImageJ 1.4 for Mac (NIH). A
subgroup of sections from each region of the brain was also
counted by eye to check the accuracy of the automated counting.
This confirmed that there was never any more than a 1%
difference between automated counts and counts made by eye.
Statistics
Food intake, instrumental responses and cell counts were
expressed as means (6SEM) and analysed using ANOVA with
dose as a repeated measure factor. Each of the eight mutually
exclusive behaviour patterns recorded during experiments 2 and 3
were treated separately. Paired comparisons between vehicle and
drug conditions were made using Dunnett’s test and other paired
comparisons used Bonferroni’s method. Statistical analysis was
carried out using the Genstat 13 statistical package.
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